• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

O6-甲基鸟嘌呤-DNA 甲基转移酶是胶质母细胞瘤侵袭的新型负效应因子。

O6-Methylguanine-DNA methyltransferase is a novel negative effector of invasion in glioblastoma multiforme.

机构信息

The Research Institute of the McGill University Health Centre, 1625 Pine Avenue West, Montreal, Quebec, H3G 1A4, Canada.

出版信息

Mol Cancer Ther. 2012 Nov;11(11):2440-50. doi: 10.1158/1535-7163.MCT-11-0977. Epub 2012 Sep 17.

DOI:10.1158/1535-7163.MCT-11-0977
PMID:22986464
Abstract

The dismal prognosis of glioblastoma multiforme (GBM) is mostly due to the high propensity of GBM tumor cells to invade. We reported an inverse relationship between GBM angiogenicity and expression of the DNA repair protein O(6)-methylguanine-DNA methyltransferase (MGMT), which has been extensively characterized for its role in resistance to alkylating agents used in GBM treatment. In the present study, given the major role of angiogenesis and invasion in GBM aggressiveness, we aimed to investigate the relationship between MGMT expression and GBM invasion. Stable overexpression of MGMT in the U87MG cell line significantly decreased invasion, altered expression of invasion-related genes, decreased expression of α(5)β(1) integrin and focal adhesion kinase, and reduced their spindle-shaped morphology and migration compared with the empty vector control. Conversely, short hairpin RNA-mediated stable knockdown of MGMT or its pharmacologic depletion in the MGMT-positive T98G cell line were required for increased invasion. The inverse relationship between MGMT and invasion was further validated in primary GBM patient-derived cell lines. Using paraffin-embedded tumors from patients with newly diagnosed GBM (n = 59), tumor MGMT promoter hypermethylation (MGMT gene silencing) was significantly associated with increased immunohistochemical expression of the proinvasive matricellular protein secreted protein acidic and rich in cysteine (SPARC; P = 0.039, χ(2) test). Taken together, our findings highlight for the first time the role of MGMT as a negative effector of GBM invasion. Future studies are warranted to elucidate the role of SPARC in the molecular mechanisms underlying the inverse relationship between MGMT and GBM invasion and the potential use of MGMT and SPARC as biomarkers of GBM invasion.

摘要

多形性胶质母细胞瘤(GBM)预后不佳,主要是由于 GBM 肿瘤细胞侵袭的高倾向。我们报道了 GBM 血管生成与 DNA 修复蛋白 O(6)-甲基鸟嘌呤-DNA 甲基转移酶(MGMT)表达之间的反比关系,MGMT 因其在抵抗用于 GBM 治疗的烷化剂方面的作用而得到广泛研究。在本研究中,鉴于血管生成和侵袭在 GBM 侵袭性中的主要作用,我们旨在研究 MGMT 表达与 GBM 侵袭之间的关系。在 U87MG 细胞系中稳定过表达 MGMT 可显著降低侵袭性,改变侵袭相关基因的表达,降低 α(5)β(1)整联蛋白和粘着斑激酶的表达,并降低其纺锤形形态和迁移,与空载体对照相比。相反,在 MGMT 阳性 T98G 细胞系中,通过短发夹 RNA 介导的 MGMT 稳定敲低或其药物耗竭,需要增加侵袭性。在原发性 GBM 患者来源的细胞系中进一步验证了 MGMT 与侵袭之间的反比关系。使用新诊断为 GBM 的患者的石蜡包埋肿瘤(n = 59),肿瘤 MGMT 启动子甲基化(MGMT 基因沉默)与富含半胱氨酸的酸性分泌蛋白(SPARC)的促侵袭免疫组织化学表达显著相关,这表明基质细胞蛋白(P = 0.039,X(2)检验)。总之,我们的研究结果首次强调了 MGMT 作为 GBM 侵袭的负效应物的作用。未来的研究需要阐明 SPARC 在 MGMT 和 GBM 侵袭之间的反比关系的分子机制中的作用,以及 MGMT 和 SPARC 作为 GBM 侵袭的生物标志物的潜在用途。

相似文献

1
O6-Methylguanine-DNA methyltransferase is a novel negative effector of invasion in glioblastoma multiforme.O6-甲基鸟嘌呤-DNA 甲基转移酶是胶质母细胞瘤侵袭的新型负效应因子。
Mol Cancer Ther. 2012 Nov;11(11):2440-50. doi: 10.1158/1535-7163.MCT-11-0977. Epub 2012 Sep 17.
2
Induction of the DNA repair gene O6-methylguanine-DNA methyltransferase by dexamethasone in glioblastomas.地塞米松对胶质母细胞瘤中DNA修复基因O6-甲基鸟嘌呤-DNA甲基转移酶的诱导作用
J Neurosurg. 2004 Oct;101(4):659-63. doi: 10.3171/jns.2004.101.4.0659.
3
In situ detection of O6-methylguanine-DNA methyltransferase messenger RNA in paraffin-embedded human astrocytic tumor tissues by nested in situ RT-PCR is useful in predicting chemotherapy-resistance of tumors.通过巢式原位逆转录聚合酶链反应对石蜡包埋的人星形细胞瘤组织中O6-甲基鸟嘌呤-DNA甲基转移酶信使核糖核酸进行原位检测,有助于预测肿瘤的化疗耐药性。
Int J Oncol. 2003 Mar;22(3):543-9.
4
[O6-methylguanine-DNA-methyltransferase (MGMT) expression in patients with glioblastoma multiforme].[多形性胶质母细胞瘤患者中O6-甲基鸟嘌呤-DNA甲基转移酶(MGMT)的表达]
Rev Med Chil. 2018 Jan;146(1):7-14. doi: 10.4067/s0034-98872018000100007.
5
Inhibition of Y-box binding protein-1 slows the growth of glioblastoma multiforme and sensitizes to temozolomide independent O6-methylguanine-DNA methyltransferase.Y 盒结合蛋白-1 的抑制作用可减缓多形性胶质母细胞瘤的生长,并使 O6-甲基鸟嘌呤-DNA 甲基转移酶独立于替莫唑胺增敏。
Mol Cancer Ther. 2009 Dec;8(12):3276-84. doi: 10.1158/1535-7163.MCT-09-0478.
6
Prognostic impact of O6-methylguanine-DNA methyltransferase silencing in patients with recurrent glioblastoma multiforme who undergo surgery and carmustine wafer implantation: a prospective patient cohort.O6-甲基鸟嘌呤-DNA甲基转移酶沉默对接受手术和卡莫司汀晶片植入的复发性多形性胶质母细胞瘤患者的预后影响:一项前瞻性患者队列研究
Cancer. 2009 Oct 15;115(20):4783-94. doi: 10.1002/cncr.24546.
7
Immunohistochemical evaluation of O6 -methylguanine DNA methyltransferase (MGMT) expression in 117 cases of glioblastoma.117例胶质母细胞瘤中O6-甲基鸟嘌呤DNA甲基转移酶(MGMT)表达的免疫组织化学评估
Neuropathology. 2014 Jun;34(3):268-76. doi: 10.1111/neup.12091. Epub 2014 Jan 7.
8
Immunohistochemical analysis of O6-methylguanine-DNA methyltransferase (MGMT) protein expression as prognostic marker in glioblastoma patients treated with radiation therapy with concomitant and adjuvant Temozolomide.O6-甲基鸟嘌呤-DNA甲基转移酶(MGMT)蛋白表达的免疫组化分析作为接受放疗联合辅助替莫唑胺治疗的胶质母细胞瘤患者的预后标志物。
J Egypt Natl Canc Inst. 2016 Mar;28(1):23-30. doi: 10.1016/j.jnci.2015.11.003. Epub 2015 Dec 10.
9
Correlation between promoter hypermethylation of the O6-methylguanine-deoxyribonucleic acid methyltransferase gene and prognosis in patients with high-grade astrocytic tumors treated with surgery, radiotherapy, and 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea-based chemotherapy.O6-甲基鸟嘌呤-脱氧核糖核酸甲基转移酶基因启动子高甲基化与接受手术、放疗及基于1-(4-氨基-2-甲基-5-嘧啶基)甲基-3-(2-氯乙基)-3-亚硝基脲化疗的高级别星形细胞瘤患者预后的相关性
Neurosurgery. 2004 Feb;54(2):349-57; discussion 357. doi: 10.1227/01.neu.0000103422.51382.99.
10
Post-transcriptional regulation of O(6)-methylguanine-DNA methyltransferase MGMT in glioblastomas.脑胶质瘤中 O(6)-甲基鸟嘌呤-DNA 甲基转移酶 MGMT 的转录后调控。
Cancer Biomark. 2011;10(3-4):185-93. doi: 10.3233/CBM-2012-0245.

引用本文的文献

1
Cancer Chemotherapeutic Effect of Vernonia Amygdalina Delile on Glioblastoma Brain Cancer Cell.垂盆草对神经胶质瘤脑癌细胞的化疗作用。
Asian Pac J Cancer Prev. 2024 Oct 1;25(10):3589-3595. doi: 10.31557/APJCP.2024.25.10.3589.
2
Two Faces of Glutaminase GLS2 in Carcinogenesis.谷氨酰胺酶GLS2在肿瘤发生中的两面性。
Cancers (Basel). 2023 Nov 24;15(23):5566. doi: 10.3390/cancers15235566.
3
Zinc finger and SCAN domain-containing 18 suppresses the proliferation, self-renewal, and drug resistance of glioblastoma cells.含锌指和SCAN结构域蛋白18抑制胶质母细胞瘤细胞的增殖、自我更新及耐药性。
Heliyon. 2023 Jun 3;9(6):e17000. doi: 10.1016/j.heliyon.2023.e17000. eCollection 2023 Jun.
4
Down-Regulation of CEND1 Expression Contributes to The Progression and Temozolomide Resistance of Glioma.CEND1表达下调促进胶质瘤进展及对替莫唑胺耐药
Cell J. 2023 Apr 1;25(4):264-272. doi: 10.22074/cellj.2022.557561.1074.
5
Up-Regulation of Cyclooxygenase-2 (COX-2) Expression by Temozolomide (TMZ) in Human Glioblastoma (GBM) Cell Lines.替莫唑胺(TMZ)上调人胶质母细胞瘤(GBM)细胞系中环氧化酶-2(COX-2)的表达。
Int J Mol Sci. 2022 Jan 28;23(3):1545. doi: 10.3390/ijms23031545.
6
MicroRNAs Regulate Cell Cycle and Cell Death Pathways in Glioblastoma.微小 RNA 调控胶质母细胞瘤中的细胞周期和细胞死亡途径。
Int J Mol Sci. 2021 Dec 17;22(24):13550. doi: 10.3390/ijms222413550.
7
Viability fingerprint of glioblastoma cell lines: roles of mitotic, proliferative, and epigenetic targets.神经胶质瘤细胞系的生存力特征:有丝分裂、增殖和表观遗传靶标的作用。
Sci Rep. 2021 Oct 13;11(1):20338. doi: 10.1038/s41598-021-99630-0.
8
Considering the Experimental use of Temozolomide in Glioblastoma Research.关于替莫唑胺在胶质母细胞瘤研究中的实验性应用。
Biomedicines. 2020 Jun 4;8(6):151. doi: 10.3390/biomedicines8060151.
9
The IL-1 Antagonist Anakinra Attenuates Glioblastoma Aggressiveness by Dampening Tumor-Associated Inflammation.白细胞介素-1拮抗剂阿那白滞素通过抑制肿瘤相关炎症减轻胶质母细胞瘤的侵袭性。
Cancers (Basel). 2020 Feb 13;12(2):433. doi: 10.3390/cancers12020433.
10
Differential Characterization of Temozolomide-Resistant Human Glioma Cells.替莫唑胺耐药的人脑胶质瘤细胞的差异特征。
Int J Mol Sci. 2018 Jan 2;19(1):127. doi: 10.3390/ijms19010127.